首页 | 本学科首页   官方微博 | 高级检索  
检索        

疏肝胶囊对实验性肝损伤的保护作用
引用本文:吴希美,谢强敏,唐法娣,王砚,曾玲晖,卞如濂.疏肝胶囊对实验性肝损伤的保护作用[J].中药药理与临床,2001,17(2):31-32.
作者姓名:吴希美  谢强敏  唐法娣  王砚  曾玲晖  卞如濂
作者单位:国家医药管理局新药研究管理中心浙江呼吸药物实验室浙江医科大学杭州 310006
摘    要:采用四氯化碳和D-氨基半乳糖诱导的大鼠实验性肝损伤动物模型研究疏肝胶囊的护肝效应,疏肝胶囊1.25、2.5和5.0g/kg显抑制四氯化碳肝损伤大鼠血清中丙氨酸转移酶、门冬氨酸转移酶活性,5.0g/kg明显抑制D-氨基半乳糖肝损伤大鼠血清丙氨酸转移酶、门冬氨酸转移酶活性,降低总胆红素含量,组织学检查也证实其护肝效应。

关 键 词:疏肝胶囊  四氯化碳  D-氨基半乳糖  实验性肝损伤

The Effect of Shugan Capsule on Experiment Liver Injury
Wu Ximei,XIE QiangMin,Tang Fadi,Wang Yan,Zeng Linghui,Bian Rulian.The Effect of Shugan Capsule on Experiment Liver Injury[J].Pharmacology and Clinics of Chinese Materia Medica,2001,17(2):31-32.
Authors:Wu Ximei  XIE QiangMin  Tang Fadi  Wang Yan  Zeng Linghui  Bian Rulian
Abstract:CCl 4 and D GLAN induced rats liver injury models were applied in this experiment to prove the hepatoprotective effect of Shugan Capsule. The results indicated that the Shugan Capsule at the doses of 1.25, 2.5, 5.0g/kg significantly decreased the serum AST and ALT activity in the CCl 4 induced liver damage. And at the dose of 5.0g/kg, Shugan Capsule also significantly inhibited the elevation of serum AST, ALT and total BITIL. Meanwhile, the histopathological examination showed the protective effect of Shugan Capsule.
Keywords:Shugan Capsule  CCl  4  D  GLAN  liver injury  animal model  
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号